A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

Phase 3 Recruiting 150 enrolled Renibus Therapeutics, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this 264 week study is is to evaluate the efficacy and safety of veverimer in treating adults with moderate-to-severe chronic kidney disease (CKD) and metabolic acidosis.

Timeline

Start: 2026-01-13
Primary completion: 2027-06
Completion: 2027-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Veverimer	Other / unclassified	9 g	—

A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

Summary

Timeline

Drugs

Indications